Cargando…
4β‐Hydroxycholesterol Level in Patients With Rheumatoid Arthritis Before vs. After Initiation of bDMARDs and Correlation With Inflammatory State
Systemic inflammation has been linked to suppressed CYP3A(4) activity. We determined 4β‐hydroxycholesterol (4βOHC), an endogenous CYP3A4 metabolite, in patients with rheumatoid arthritis (RA) before and after treatment with biological disease‐modifying antirheumatic drugs (bDMARDs). The 4βOHC was co...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351010/ https://www.ncbi.nlm.nih.gov/pubmed/27991741 http://dx.doi.org/10.1111/cts.12431 |
_version_ | 1782514707717947392 |
---|---|
author | Wollmann, BM Syversen, SW Lie, E Gjestad, C Mehus, LL Olsen, IC Molden, E |
author_facet | Wollmann, BM Syversen, SW Lie, E Gjestad, C Mehus, LL Olsen, IC Molden, E |
author_sort | Wollmann, BM |
collection | PubMed |
description | Systemic inflammation has been linked to suppressed CYP3A(4) activity. We determined 4β‐hydroxycholesterol (4βOHC), an endogenous CYP3A4 metabolite, in patients with rheumatoid arthritis (RA) before and after treatment with biological disease‐modifying antirheumatic drugs (bDMARDs). The 4βOHC was compared in 41 patients before and 2–5 months after initiating TNFα inhibitors (n = 31), IL‐6 inhibitors (n = 5), or B‐cell inhibitors (n = 5). Correlations between 4βOHC and inflammatory markers (C‐reactive protein (CRP) and erythrocyte sedimentation rate (ESR)) were also tested before and after bDMARDs. 4βOHC did not differ following bDMARD treatment (P = 0.6), nor in patients who started with IL‐6 inhibitors (median 51.6 vs. 50.6 nmol/L). The 4βOHC and CRP/ESR did not correlate before treatment (P > 0.5), but correlated significantly after bDMARDs (CRP = Spearman r ‐0.40; P < 0.01; ESR = r ‐0.34; P = 0.028) suggesting that mainly non‐CYP3A4‐suppressive cytokines were reduced during treatment. Thus, this study does not support a generally regained CYP3A4 phenotype in patients with RA following initiation of bDMARDs. |
format | Online Article Text |
id | pubmed-5351010 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-53510102017-05-23 4β‐Hydroxycholesterol Level in Patients With Rheumatoid Arthritis Before vs. After Initiation of bDMARDs and Correlation With Inflammatory State Wollmann, BM Syversen, SW Lie, E Gjestad, C Mehus, LL Olsen, IC Molden, E Clin Transl Sci Research Systemic inflammation has been linked to suppressed CYP3A(4) activity. We determined 4β‐hydroxycholesterol (4βOHC), an endogenous CYP3A4 metabolite, in patients with rheumatoid arthritis (RA) before and after treatment with biological disease‐modifying antirheumatic drugs (bDMARDs). The 4βOHC was compared in 41 patients before and 2–5 months after initiating TNFα inhibitors (n = 31), IL‐6 inhibitors (n = 5), or B‐cell inhibitors (n = 5). Correlations between 4βOHC and inflammatory markers (C‐reactive protein (CRP) and erythrocyte sedimentation rate (ESR)) were also tested before and after bDMARDs. 4βOHC did not differ following bDMARD treatment (P = 0.6), nor in patients who started with IL‐6 inhibitors (median 51.6 vs. 50.6 nmol/L). The 4βOHC and CRP/ESR did not correlate before treatment (P > 0.5), but correlated significantly after bDMARDs (CRP = Spearman r ‐0.40; P < 0.01; ESR = r ‐0.34; P = 0.028) suggesting that mainly non‐CYP3A4‐suppressive cytokines were reduced during treatment. Thus, this study does not support a generally regained CYP3A4 phenotype in patients with RA following initiation of bDMARDs. John Wiley and Sons Inc. 2016-11-05 2017-01 /pmc/articles/PMC5351010/ /pubmed/27991741 http://dx.doi.org/10.1111/cts.12431 Text en © 2016 The Authors. Clinical and Translational Science published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Research Wollmann, BM Syversen, SW Lie, E Gjestad, C Mehus, LL Olsen, IC Molden, E 4β‐Hydroxycholesterol Level in Patients With Rheumatoid Arthritis Before vs. After Initiation of bDMARDs and Correlation With Inflammatory State |
title | 4β‐Hydroxycholesterol Level in Patients With Rheumatoid Arthritis Before vs. After Initiation of bDMARDs and Correlation With Inflammatory State |
title_full | 4β‐Hydroxycholesterol Level in Patients With Rheumatoid Arthritis Before vs. After Initiation of bDMARDs and Correlation With Inflammatory State |
title_fullStr | 4β‐Hydroxycholesterol Level in Patients With Rheumatoid Arthritis Before vs. After Initiation of bDMARDs and Correlation With Inflammatory State |
title_full_unstemmed | 4β‐Hydroxycholesterol Level in Patients With Rheumatoid Arthritis Before vs. After Initiation of bDMARDs and Correlation With Inflammatory State |
title_short | 4β‐Hydroxycholesterol Level in Patients With Rheumatoid Arthritis Before vs. After Initiation of bDMARDs and Correlation With Inflammatory State |
title_sort | 4β‐hydroxycholesterol level in patients with rheumatoid arthritis before vs. after initiation of bdmards and correlation with inflammatory state |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351010/ https://www.ncbi.nlm.nih.gov/pubmed/27991741 http://dx.doi.org/10.1111/cts.12431 |
work_keys_str_mv | AT wollmannbm 4bhydroxycholesterollevelinpatientswithrheumatoidarthritisbeforevsafterinitiationofbdmardsandcorrelationwithinflammatorystate AT syversensw 4bhydroxycholesterollevelinpatientswithrheumatoidarthritisbeforevsafterinitiationofbdmardsandcorrelationwithinflammatorystate AT liee 4bhydroxycholesterollevelinpatientswithrheumatoidarthritisbeforevsafterinitiationofbdmardsandcorrelationwithinflammatorystate AT gjestadc 4bhydroxycholesterollevelinpatientswithrheumatoidarthritisbeforevsafterinitiationofbdmardsandcorrelationwithinflammatorystate AT mehusll 4bhydroxycholesterollevelinpatientswithrheumatoidarthritisbeforevsafterinitiationofbdmardsandcorrelationwithinflammatorystate AT olsenic 4bhydroxycholesterollevelinpatientswithrheumatoidarthritisbeforevsafterinitiationofbdmardsandcorrelationwithinflammatorystate AT moldene 4bhydroxycholesterollevelinpatientswithrheumatoidarthritisbeforevsafterinitiationofbdmardsandcorrelationwithinflammatorystate |